The store will not work correctly when cookies are disabled.
3,4-Dichloro-N-[4-(3-nitro-phenyl)-thiazol-2-yl]-benzenesulfonamide
ID: ALA136826
PubChem CID: 10526613
Max Phase: Preclinical
Molecular Formula: C15H9Cl2N3O4S2
Molecular Weight: 430.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1cccc(-c2csc(NS(=O)(=O)c3ccc(Cl)c(Cl)c3)n2)c1
Standard InChI: InChI=1S/C15H9Cl2N3O4S2/c16-12-5-4-11(7-13(12)17)26(23,24)19-15-18-14(8-25-15)9-2-1-3-10(6-9)20(21)22/h1-8H,(H,18,19)
Standard InChI Key: SIXKRNBZGWCFKP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
4.4792 -2.5167 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.9667 -2.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4417 -2.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9250 -2.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3667 -4.3292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -2.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0042 -2.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4417 -1.9167 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.4000 -1.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0042 -3.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3667 -3.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8875 -2.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5250 -3.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9917 -1.9042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -1.8417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8875 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8500 -4.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8875 -4.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0417 -3.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5167 -2.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0375 -2.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5250 -4.3042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.5625 -3.7042 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.8500 -3.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3667 -2.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8500 -2.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 2 0
5 11 1 0
6 4 1 0
7 1 1 0
8 3 1 0
9 8 1 0
10 7 2 0
11 16 2 0
12 6 1 0
13 10 1 0
14 1 2 0
15 1 2 0
16 12 1 0
17 5 1 0
18 5 2 0
19 21 1 0
20 7 1 0
21 20 2 0
22 13 1 0
23 19 1 0
24 26 2 0
25 12 2 0
26 25 1 0
19 13 2 0
9 6 2 0
11 24 1 0
M CHG 2 5 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 430.29 | Molecular Weight (Monoisotopic): 428.9412 | AlogP: 4.83 | #Rotatable Bonds: 5 |
Polar Surface Area: 102.20 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.71 | CX Basic pKa: ┄ | CX LogP: 4.99 | CX LogD: 4.41 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.46 | Np Likeness Score: -2.52 |
References
1. Röver S, Cesura AM, Huguenin P, Kettler R, Szente A.. (1997) Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase., 40 (26): [PMID:9435907] [10.1021/jm970467t] |